Moreover, by isolating residual “normal” HSC from these patients (defined as CD99− TIM3− CD34+ CD38− Lin−), they identified a number of mutations in critical epigenetic regulators frequently mutated in AML and MDS. The gene discussed is CD34; the disease is acute myeloid leukemia.